I have been patiently waiting for a bull market to begin in Biogen Inc (NASDAQ:BIIB) stock. I got my hopes up after the United States presidential election results revealed that Donald Trump was the victor, and BIIB stock-and the entire biotech sector-surged in the wake of this result.
Little came of the initial surge, and with good reason: Donald Trump has made it clear that he will no longer allow the predatory pricing schemes that have tarnished the pharmaceutical sector to continue.
In 2015, these.
Den vollständigen Artikel lesen ...